Case Overview: The U.S. Supreme Court has ruled in the Roundup herbicide litigation that federal pesticide law preempts certain state-law failure-to-warn claims, a decision that could significantly narrow the litigation landscape for plaintiffs alleging glyphosate caused their cancer.

Consumers Affected: Individuals who filed or are considering filing lawsuits alleging exposure to Roundup herbicide caused non-Hodgkin's lymphoma or other cancers

Court: Supreme Court of the United States

Latest Development: The Supreme Court issued a ruling interpreting preemption language under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), finding that state-law warning requirements that differ from or add to federal EPA-approved labeling are barred

Supreme Court Rules Federal Law Preempts Key Roundup Warning Claims

The U.S. Supreme Court has issued a consequential ruling in the long-running Roundup herbicide litigation, holding that federal pesticide law bars state-law claims demanding cancer warnings that go beyond what the Environmental Protection Agency has approved. The decision could reshape the future of thousands of pending lawsuits against Bayer, Monsanto's parent company, by eliminating a central theory plaintiffs have relied upon.

According to an analysis published by the Drug & Device Law Blog, the ruling centers on the preemption provisions of the Federal Insecticide, Fungicide, and Rodenticide Act, known as FIFRA. The Court interpreted the statute's language — which bars state requirements that are "different from" or "in addition to" federally mandated labeling — as meaning precisely what it says.

What the Court Decided

The Supreme Court's ruling addresses a core question that has divided lower courts for years: whether plaintiffs can use state tort law to argue that Roundup's label should have included a cancer warning, even when the EPA has repeatedly concluded that glyphosate, the active ingredient in Roundup, does not warrant such a warning.

The EPA reaffirmed that position as recently as 2019, finding that glyphosate does not cause cancer and that no cancer-related warning was required on the product's label. The Court's decision, according to the Drug & Device Law Blog analysis, gives that regulatory determination significant legal weight — holding that a state-law duty to warn of cancer risks would impose a labeling requirement that is both "different from" and "in addition to" what federal regulators have authorized.

Background on the Roundup Litigation

Roundup has been at the center of one of the largest mass tort litigations in U.S. history. Plaintiffs — many of them agricultural workers, landscapers, and homeowners — allege that long-term exposure to glyphosate caused them to develop non-Hodgkin's lymphoma. The litigation intensified following a 2015 assessment by the International Agency for Research on Cancer, which classified glyphosate as "probably carcinogenic to humans."

Bayer, which acquired Monsanto in 2018, has faced billions of dollars in jury verdicts and settlements. The company has consistently argued that its product is safe when used as directed and that the EPA's scientific conclusions should shield it from state-law claims.

What This Means for Plaintiffs

The ruling represents a significant legal development for the tens of thousands of individuals with active Roundup claims. By affirming the preemptive force of the EPA's labeling determination, the decision removes — or at minimum substantially weakens — the failure-to-warn theory that has underpinned much of the litigation.

However, the full scope of the ruling's impact on pending cases will depend on how lower courts apply it going forward. Legal analysts note that some claims, depending on how they are structured, may still proceed under other theories.

What's Next

Plaintiffs' attorneys are expected to assess how the ruling affects pending cases in federal and state courts. Courts overseeing remaining Roundup litigation will likely be asked to apply the Supreme Court's interpretation to individual claims in the months ahead.

For individuals with pending claims or those who believe they may have been harmed by Roundup exposure, the decision underscores the importance of consulting with a qualified attorney to understand how this development may affect their specific situation.

Lawsuit: In re Roundup Products Liability Litigation

Court: Supreme Court of the United States; MDL proceedings in U.S. District Court, N.D. California

MDL Number: MDL No. 2741

Status: Supreme Court preemption ruling issued; impact on pending cases pending further lower court proceedings

Have you been diagnosed with non-Hodgkin's lymphoma or another illness you believe is connected to Roundup exposure? This ruling may affect open claims — check eligibility below.